Mylan (MYL US) Reportedly in advanced stage talks to acquire European drug assets from Abbott; deal said to be valued at several billion dollars - press
- The purchase of the European based portfolio of off patent drugs reportedly will be structured as a tax inversion deal that will allow Mylan to redomicile in Switzerland